These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23108543)

  • 1. Functional diversity on synaptic plasticity mediated by endocannabinoids.
    Cachope R
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3242-53. PubMed ID: 23108543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids and synaptic function in the CNS.
    Hashimotodani Y; Ohno-Shosaku T; Kano M
    Neuroscientist; 2007 Apr; 13(2):127-37. PubMed ID: 17404373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid signaling and synaptic plasticity in the brain.
    Zhu PJ
    Crit Rev Neurobiol; 2006; 18(1-2):113-24. PubMed ID: 17725514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrograde signalling by endocannabinoids.
    Vaughan CW; Christie MJ
    Handb Exp Pharmacol; 2005; (168):367-83. PubMed ID: 16596781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid-mediated synaptic plasticity in the CNS.
    Chevaleyre V; Takahashi KA; Castillo PE
    Annu Rev Neurosci; 2006; 29():37-76. PubMed ID: 16776579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength.
    Mackie K
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S19-23. PubMed ID: 16570100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons.
    Edwards JG; Gibson HE; Jensen T; Nugent F; Walther C; Blickenstaff J; Kauer JA
    Hippocampus; 2012 Feb; 22(2):209-21. PubMed ID: 21069781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices.
    Báldi R; Ghosh D; Grueter BA; Patel S
    Curr Protoc Neurosci; 2016 Apr; 75():6.29.1-6.29.19. PubMed ID: 27063786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors.
    Haj-Dahmane S; Shen RY
    J Pharmacol Exp Ther; 2009 Oct; 331(1):186-96. PubMed ID: 19592666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.
    Sidhpura N; Parsons LH
    Neuropharmacology; 2011 Dec; 61(7):1070-87. PubMed ID: 21669214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do cannabinoid receptors have more than one endogenous ligand?
    Di Marzo V; De Petrocellis L
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic nanoscale components of retrograde synaptic signaling.
    Barti B; Dudok B; Kenesei K; Zöldi M; Miczán V; Balla GY; Zala D; Tasso M; Sagheddu C; Kisfali M; Tóth B; Ledri M; Vizi ES; Melis M; Barna L; Lenkei Z; Soltész I; Katona I
    Sci Adv; 2024 May; 10(22):eado0077. PubMed ID: 38809980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks.
    Morris G; Walder K; Kloiber S; Amminger P; Berk M; Bortolasci CC; Maes M; Puri BK; Carvalho AF
    Pharmacol Res; 2021 Aug; 170():105729. PubMed ID: 34119623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens.
    Robbe D; Alonso G; Manzoni OJ
    Ann N Y Acad Sci; 2003 Nov; 1003():212-25. PubMed ID: 14684448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of endocannabinoid control of synaptic plasticity.
    Winters BL; Vaughan CW
    Neuropharmacology; 2021 Oct; 197():108736. PubMed ID: 34343612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate.
    Roloff AM; Thayer SA
    Mol Pharmacol; 2009 Apr; 75(4):892-900. PubMed ID: 19118122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic functions of endocannabinoid signaling in health and disease.
    Araque A; Castillo PE; Manzoni OJ; Tonini R
    Neuropharmacology; 2017 Sep; 124():13-24. PubMed ID: 28625718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary PUFAs and Exercise Dynamic Actions on Endocannabinoids in Brain: Consequences for Neural Plasticity and Neuroinflammation.
    Park Y; Watkins BA
    Adv Nutr; 2022 Oct; 13(5):1989-2001. PubMed ID: 35675221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.